These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7915367)

  • 21. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
    Escobales N; Crespo MJ; Altieri PI; Furilla RA
    J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaco-economic assessment of the HMG-CoA reductase inhibitors.
    Smart AJ; Walters L
    S Afr Med J; 1994 Dec; 84(12):834-7. PubMed ID: 7570232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA; Roos BE; Kvidal P; Eriksson LO; Block GA; Neafus RP; Haigh JR
    Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approximate equivalent rosuvastatin doses for temporary statin interchange programs.
    Kendrach MG; Kelly-Freeman M
    Ann Pharmacother; 2004; 38(7-8):1286-92. PubMed ID: 15187217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of low density lipoprotein lowering by hypolipidemic agents.
    Kesäniemi YA
    Ann Med; 1991 Apr; 23(2):195-8. PubMed ID: 2069796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Flotation mass-spectra and surface potential of low density lipoprotein particles of hyperlipidemic patients after forced abolishment of lavostatin treatment].
    Morozkin AD; Sumarokov AB; Medvedeva NV; Liakishev AA
    Biomed Khim; 2003; 49(6):566-75. PubMed ID: 16119085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations.
    Med Lett Drugs Ther; 1992 Jun; 34(872):57-8. PubMed ID: 1593973
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipid lowering efficacy between morning and evening simvastatin treatment: a randomized double-blind study.
    Tharavanij T; Wongtanakarn S; Lerdvuthisopon N; Teeraaunkul S; Youngsriphithak P; Sritipsukho P
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S109-13. PubMed ID: 21294404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed-dose combination fenofibrate/pravastatin 160/40 mg versus simvastatin 20 mg monotherapy in adults with type 2 diabetes and mixed hyperlipidemia uncontrolled with simvastatin 20 mg: a double-blind, randomized comparative study.
    Farnier M; Steinmetz A; Retterstøl K; Császár A
    Clin Ther; 2011 Jan; 33(1):1-12. PubMed ID: 21397769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of ezetimibe/simvastatin, rosuvastatin, and atorvastatin in uncontrolled hyperlipidemia patients.
    Furman A; Meier JL; Malmstrom RA; Lopez JR; Schaefer S
    Am J Manag Care; 2011; 17(8):538-44. PubMed ID: 21851141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine.
    Rehman MA; al-Sulaiman MH; Mousa DH; al-Hawas FA; Abdalla AH; Rassoul Z; al-Khader AA
    Transplantation; 1995 Aug; 60(4):397-9. PubMed ID: 7652773
    [No Abstract]   [Full Text] [Related]  

  • 34. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.
    Choudhry NK; Levin R; Winkelmayer WC
    Heart; 2007 Aug; 93(8):945-51. PubMed ID: 17344334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG; Davidson MH
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
    Cummings MH; Watts GF
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():383-5. PubMed ID: 7979108
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia.
    McCrindle BW; Helden E; Cullen-Dean G; Conner WT
    Pediatr Res; 2002 Jun; 51(6):715-21. PubMed ID: 12032266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM; Thompson GR
    Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
    Morris MJ; Gilbert JD; Hsieh JY; Matuszewski BK; Ramjit HG; Bayne WF
    Biol Mass Spectrom; 1993 Jan; 22(1):1-8. PubMed ID: 8431499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins and coronary heart disease.
    Thompson GR
    Lancet; 1996 Jul; 348(9019):57. PubMed ID: 8691944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.